[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356403-105":59,"doc-detail-356403-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-dynamic-myeloid-enriched-microenvironment-of-glioblastoma-a-major-challenge-to-immunotherapy-efficacy","The dynamic myeloid-enriched microenvironment of glioblastoma: a major challenge to immunotherapy efficacy","","Glioblastoma is the most common and aggressive adult brain tumor, and existing treatments deliver limited efficacy. This review examines how the glioblastoma tumor microenvironment constrains immunotherapy by driving strong immunosuppression, shaped by factors such as tumor mutational profile, prior conventional therapies, and other biological regulators. The work summarizes key modulating elements of the myeloid-enriched microenvironment and emphasizes the value of complex, integrative experimental models to guide next-generation personalized immunotherapeutic strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-dynamic-myeloid-enriched-microenvironment-of-glioblastoma-a-major-challenge-to-immunotherapy-efficacy/356403/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-dynamic-myeloid-enriched-microenvironment-of-glioblastoma-a-major-challenge-to-immunotherapy-efficacy/356403.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does the glioblastoma tumor microenvironment play in limiting immunotherapy efficacy?","Question",{"text":112,"@type":113},"The tumor microenvironment creates profound immunosuppression in glioblastoma, which negatively impacts the effectiveness of immunotherapeutic approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which factors are discussed as modulating the glioblastoma microenvironment?",{"text":117,"@type":113},"The review highlights factors such as tumor cell mutational profiles, effects of previous conventional treatment lines, and other biological regulators involved in modulating the tumor microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does the review emphasize complex and integrative models?",{"text":121,"@type":113},"Because studying the microenvironment requires capturing multiple interacting components, integrative models are presented as important tools to better analyze and ultimately improve immunotherapeutic strategies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356403,1790196521,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Review  \nPUBLISHED 10 February 2026  \nDOI 10.3389/fimmu.2026.1755073  \nOPEN ACCESS  \nEDITED BY  \nSiyi Wanggou,  \nCentral South University, China  \nREVIEWED BY  \nMark Elia Issa,  \nKarolinska Institutet (KI), Sweden Enes Demir,  \nKarolinska Institutet (KI), Sweden  \n*CORRESPONDENCE  \nLoïc Reppel  \n [loic.reppel@univ-lorraine.fr](loic.reppel@univ-lorraine.fr)[ ](loic.reppel@univ-lorraine.fr)Cindy Lamorlette  \n [cindy.lamorlette@univ-lorraine.fr](cindy.lamorlette@univ-lorraine.fr)[ ](cindy.lamorlette@univ-lorraine.fr)RECEIVED 26 November 2025 REVISED 16 January 2026 ACCEPTED 26 January 2026 PUBLISHED 10 February 2026  \nCITATION  \nLamorlette C, Boura C, Pinel S, Bensoussan D, Dotti G, Alanio C and Reppel L (2026) The dynamic myeloidenriched microenvironment of glioblastoma: a major challenge to immunotherapy efﬁcacy.  \nFront. Immunol. 17:1755073 .  \ndoi: 10.3389/fimmu.2026.1755073  \nCOPYRIGHT  \n© 2026 Lamorlette, Boura, Pinel, Bensoussan, Dotti, Alanio and Reppel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe dynamic myeloid-enriched microenvironment of glioblastoma: a major challenge to immunotherapy efﬁcacy  \nCindy Lamorlette 1*, C´edric Boura 2, Sophie Pinel 2, Danièle Bensoussan 1,3, Gianpietro Dotti 4, C´ecile Alanio 5,6,7 and Loïc Reppel 1,3*  \n1 Universite´ de Lorraine, Centre National de Recherche Scientiﬁque (CNRS), Unité Mixte de Recherche (UMR) 7365 Ingénierie Moléculaire, Cellulaire et Physiopathologie (IMoPA), Nancy, France, 2 Universite´ de Lorraine, Centre National de Recherche Scientiﬁque (CNRS), Unité Mixte de Recherche (UMR)7039 Centre de Recherche en Automatique de Nancy (CRAN), Nancy, France, 3Centre Hospitalier Re´ gional Universitaire (CHRU) Nancy, Cell Therapy and Tissue Bank Unit, MTInov Bioproduction and Biotherapy Integrator, Nancy, France, 4 Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States, 5 Universite´ Paris Cite´, Inserm, Paris Cardiovascular Research Center (PARCC), Paris, France, 6 Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States, 7 Biology Department, Foch Hospital, Suresnes, France  \nGlioblastoma (GBM) is the most common and aggressive brain tumor in adults, and current treatments remain poorly efﬁcient. In this context, immunotherapies may represent promising strategies. However, their efﬁcacy is often limited by a strong negative impact of the tumor microenvironment (TME) of glioblastoma. Several factors such as tumor cells mutational proﬁle, previous lines of conventional treatments, or biological factors, have been shown as involved in TME modulation. In this review, our goal is to give an overview of the main modulating factors of the TME of glioblastoma tumors. We will also highlight the importance of developing complex and integrative models to study this microenvironment. At the end, by highlighting critical components of the glioblastoma microenvironment, this review aims to support the development of next-generation, more effective and personalized immunotherapeutic strategies.  \nKEYWORDS  \nglioblastoma, immunotherapy, microenvironment, modulating factors, myeloid cells  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nLamorlette et al. 10.3389/ﬁmmu.2026.1755073  \nGRAPHICAL ABSTRACT  \nCreated in BioRender. Lamorlette, C. (2026) [https://BioRender.com/0j9owwq](https://BioRender.com/0j9owwq).  \n1 Introduction  \nGlioblastomas (GBMs) account for 50% of Central Nervous System (CNS) malignancies, making them the most common cancer in this category.","cbCaiqWLDeWUn1p9","https://ap.wps.com/l/cbCaiqWLDeWUn1p9","pdf",6359647,15,"English","# Introduction\n## Standard of care and clinical context\n# Review scope: microenvironment modulation\n## Importance of integrative models\n# Implications for next-generation immunotherapy","[{\"question\":\"What role does the glioblastoma tumor microenvironment play in limiting immunotherapy efficacy?\",\"answer\":\"The tumor microenvironment creates profound immunosuppression in glioblastoma, which negatively impacts the effectiveness of immunotherapeutic approaches.\"},{\"question\":\"Which factors are discussed as modulating the glioblastoma microenvironment?\",\"answer\":\"The review highlights factors such as tumor cell mutational profiles, effects of previous conventional treatment lines, and other biological regulators involved in modulating the tumor microenvironment.\"},{\"question\":\"Why does the review emphasize complex and integrative models?\",\"answer\":\"Because studying the microenvironment requires capturing multiple interacting components, integrative models are presented as important tools to better analyze and ultimately improve immunotherapeutic strategies.\"}]","The dynamic myeloid-enriched microenvironment of glioblastoma: a major challenge to immunotherapy efficacy | PDF",1790125205,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64c458a29311b8afab06492f51cd44c3.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae465d13ef92622a623311ce14bf9b47.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7f9c7000a2026bdb67135eae953c1b4.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edc74440fafefb6006b7409acb8a9129.webp",980,1385]